Patents by Inventor Andreas Ruhmann

Andreas Ruhmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists specific for the corticotropin-releasing factor receptor type 2 (CRFR2)
    Patent number: 6846803
    Abstract: The present invention relates to an antagonist of the ligand of the Corticotropin-Releasing Factor Receptor, type 2 (CRFR2) lacking the 8 to 10 N-terminal amino acids of native sauvagine. The present invention also relates to an antagonist of the ligand of the Corticotropin-Releasing Factor Receptor, type 2 (CRFR2) lacking the 11 N-terminal amino acids of native sauvagine, wherein the N-terminal amino acid of said antagonist is a charged amino acid. Furthermore, the present invention relates to a polynucleotide encoding the antagonist of the present invention, a vector comprising the polynucleotide of the present invention, and a host comprising the polynucleotide or the vector of the present invention. Also described are a method for producing the antagonist of the present invention, antibodies directed the antagonist of the present invention, as well as anti-idiotypic antibodies directed against the antibody of the present invention.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: January 25, 2005
    Assignee: Max Planck Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Joachim Spiess, Andreas Ruhmann